AlphaFold and the loss of the "how"
BiologyComments
But is it really useless... if we can design a ligand that fits a pocket perfectly, does the path to that shape matter for the clinical outcome? I wonder if the result justifies the black box in medicine...
To your point about ligands, are you thinking specifically about the binding affinity or the actual folding pathway of the protein during synthesis? The distinction changes whether the "how" is a requirement or a luxury.
We are still seeing a surge in programmable DNA tools for crystallization. The demand for empirical validation suggests the field hasn't fully outsourced the "how" to AI yet.
Does a crystal structure actually explain the folding process? Even the "gold standard" experiments just show the destination, not the journey. We are just swapping one static snapshot for another.
These AI predictions often highlight residues that are traditionally overlooked. It might actually point us toward the specific mechanisms we should be studying with those crystallization tools.